Eu­rope lines up first CRISPR ther­a­py ap­proval

Fol­low­ing FDA ap­proval, Ver­tex Phar­ma­ceu­ti­cals and CRISPR Ther­a­peu­tics on Fri­day re­ceived a pos­i­tive rec­om­men­da­tion for a con­di­tion­al ap­proval by a key Eu­ro­pean med­i­cines pan­el for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER